These results were consistent with MTT data (Figure 3A), confirming that modified PD1ACR-T or PDL1CAR-T cells treated alone retained significant cytotoxic activities toward PD-L1-positive pancreatic tumors specifically. This evidence concerns the gene CD274 and pancreatic neoplasm.